nodes	percent_of_prediction	percent_of_DWPC	metapath
Escitalopram—CYP3A4—bone cancer	0.688	1	CbGaD
Escitalopram—Citalopram—CYP3A4—bone cancer	0.00469	1	CrCbGaD
Escitalopram—Conjunctivitis—Doxorubicin—bone cancer	0.000177	0.000576	CcSEcCtD
Escitalopram—Haemorrhage—Epirubicin—bone cancer	0.000176	0.000575	CcSEcCtD
Escitalopram—Hepatitis—Epirubicin—bone cancer	0.000176	0.000575	CcSEcCtD
Escitalopram—Eye disorder—Methotrexate—bone cancer	0.000176	0.000574	CcSEcCtD
Escitalopram—Tinnitus—Methotrexate—bone cancer	0.000176	0.000573	CcSEcCtD
Escitalopram—Hypoaesthesia—Epirubicin—bone cancer	0.000175	0.000572	CcSEcCtD
Escitalopram—Asthenia—Cisplatin—bone cancer	0.000175	0.00057	CcSEcCtD
Escitalopram—Pharyngitis—Epirubicin—bone cancer	0.000175	0.00057	CcSEcCtD
Escitalopram—Cardiac disorder—Methotrexate—bone cancer	0.000175	0.00057	CcSEcCtD
Escitalopram—Sweating—Doxorubicin—bone cancer	0.000174	0.000568	CcSEcCtD
Escitalopram—Urinary tract disorder—Epirubicin—bone cancer	0.000174	0.000568	CcSEcCtD
Escitalopram—Oedema peripheral—Epirubicin—bone cancer	0.000174	0.000566	CcSEcCtD
Escitalopram—Haematuria—Doxorubicin—bone cancer	0.000173	0.000565	CcSEcCtD
Escitalopram—Connective tissue disorder—Epirubicin—bone cancer	0.000173	0.000565	CcSEcCtD
Escitalopram—Urethral disorder—Epirubicin—bone cancer	0.000173	0.000563	CcSEcCtD
Escitalopram—Hepatobiliary disease—Doxorubicin—bone cancer	0.000172	0.00056	CcSEcCtD
Escitalopram—Epistaxis—Doxorubicin—bone cancer	0.000171	0.000559	CcSEcCtD
Escitalopram—Angiopathy—Methotrexate—bone cancer	0.000171	0.000557	CcSEcCtD
Escitalopram—Sinusitis—Doxorubicin—bone cancer	0.000171	0.000556	CcSEcCtD
Escitalopram—Immune system disorder—Methotrexate—bone cancer	0.00017	0.000555	CcSEcCtD
Escitalopram—Visual impairment—Epirubicin—bone cancer	0.00017	0.000554	CcSEcCtD
Escitalopram—Mediastinal disorder—Methotrexate—bone cancer	0.00017	0.000553	CcSEcCtD
Escitalopram—Agranulocytosis—Doxorubicin—bone cancer	0.00017	0.000553	CcSEcCtD
Escitalopram—Chills—Methotrexate—bone cancer	0.000169	0.000551	CcSEcCtD
Escitalopram—Diarrhoea—Cisplatin—bone cancer	0.000167	0.000544	CcSEcCtD
Escitalopram—Erythema multiforme—Epirubicin—bone cancer	0.000167	0.000543	CcSEcCtD
Escitalopram—Alopecia—Methotrexate—bone cancer	0.000167	0.000543	CcSEcCtD
Escitalopram—Bradycardia—Doxorubicin—bone cancer	0.000166	0.000541	CcSEcCtD
Escitalopram—Mental disorder—Methotrexate—bone cancer	0.000165	0.000538	CcSEcCtD
Escitalopram—Eye disorder—Epirubicin—bone cancer	0.000165	0.000537	CcSEcCtD
Escitalopram—Tinnitus—Epirubicin—bone cancer	0.000164	0.000536	CcSEcCtD
Escitalopram—Malnutrition—Methotrexate—bone cancer	0.000164	0.000535	CcSEcCtD
Escitalopram—Erythema—Methotrexate—bone cancer	0.000164	0.000535	CcSEcCtD
Escitalopram—Haemoglobin—Doxorubicin—bone cancer	0.000164	0.000534	CcSEcCtD
Escitalopram—Flushing—Epirubicin—bone cancer	0.000164	0.000533	CcSEcCtD
Escitalopram—Cardiac disorder—Epirubicin—bone cancer	0.000164	0.000533	CcSEcCtD
Escitalopram—Rhinitis—Doxorubicin—bone cancer	0.000164	0.000533	CcSEcCtD
Escitalopram—Haemorrhage—Doxorubicin—bone cancer	0.000163	0.000532	CcSEcCtD
Escitalopram—Hepatitis—Doxorubicin—bone cancer	0.000163	0.000532	CcSEcCtD
Escitalopram—Hypoaesthesia—Doxorubicin—bone cancer	0.000162	0.000529	CcSEcCtD
Escitalopram—Pharyngitis—Doxorubicin—bone cancer	0.000162	0.000528	CcSEcCtD
Escitalopram—Urinary tract disorder—Doxorubicin—bone cancer	0.000161	0.000525	CcSEcCtD
Escitalopram—Oedema peripheral—Doxorubicin—bone cancer	0.000161	0.000524	CcSEcCtD
Escitalopram—Dysgeusia—Methotrexate—bone cancer	0.000161	0.000524	CcSEcCtD
Escitalopram—Connective tissue disorder—Doxorubicin—bone cancer	0.00016	0.000523	CcSEcCtD
Escitalopram—Angiopathy—Epirubicin—bone cancer	0.00016	0.000521	CcSEcCtD
Escitalopram—Urethral disorder—Doxorubicin—bone cancer	0.00016	0.000521	CcSEcCtD
Escitalopram—Immune system disorder—Epirubicin—bone cancer	0.000159	0.000519	CcSEcCtD
Escitalopram—Mediastinal disorder—Epirubicin—bone cancer	0.000159	0.000518	CcSEcCtD
Escitalopram—Back pain—Methotrexate—bone cancer	0.000159	0.000517	CcSEcCtD
Escitalopram—Chills—Epirubicin—bone cancer	0.000158	0.000516	CcSEcCtD
Escitalopram—Arrhythmia—Epirubicin—bone cancer	0.000158	0.000513	CcSEcCtD
Escitalopram—Visual impairment—Doxorubicin—bone cancer	0.000157	0.000512	CcSEcCtD
Escitalopram—Alopecia—Epirubicin—bone cancer	0.000156	0.000508	CcSEcCtD
Escitalopram—Vomiting—Cisplatin—bone cancer	0.000155	0.000506	CcSEcCtD
Escitalopram—Vision blurred—Methotrexate—bone cancer	0.000155	0.000504	CcSEcCtD
Escitalopram—Mental disorder—Epirubicin—bone cancer	0.000155	0.000504	CcSEcCtD
Escitalopram—Erythema multiforme—Doxorubicin—bone cancer	0.000154	0.000503	CcSEcCtD
Escitalopram—Rash—Cisplatin—bone cancer	0.000154	0.000501	CcSEcCtD
Escitalopram—Dermatitis—Cisplatin—bone cancer	0.000154	0.000501	CcSEcCtD
Escitalopram—Erythema—Epirubicin—bone cancer	0.000154	0.0005	CcSEcCtD
Escitalopram—Malnutrition—Epirubicin—bone cancer	0.000154	0.0005	CcSEcCtD
Escitalopram—Eye disorder—Doxorubicin—bone cancer	0.000152	0.000497	CcSEcCtD
Escitalopram—Ill-defined disorder—Methotrexate—bone cancer	0.000152	0.000496	CcSEcCtD
Escitalopram—Tinnitus—Doxorubicin—bone cancer	0.000152	0.000496	CcSEcCtD
Escitalopram—Anaemia—Methotrexate—bone cancer	0.000152	0.000494	CcSEcCtD
Escitalopram—Flushing—Doxorubicin—bone cancer	0.000151	0.000494	CcSEcCtD
Escitalopram—Cardiac disorder—Doxorubicin—bone cancer	0.000151	0.000494	CcSEcCtD
Escitalopram—Flatulence—Epirubicin—bone cancer	0.000151	0.000493	CcSEcCtD
Escitalopram—Tension—Epirubicin—bone cancer	0.000151	0.000491	CcSEcCtD
Escitalopram—Dysgeusia—Epirubicin—bone cancer	0.00015	0.00049	CcSEcCtD
Escitalopram—Nervousness—Epirubicin—bone cancer	0.000149	0.000486	CcSEcCtD
Escitalopram—Back pain—Epirubicin—bone cancer	0.000149	0.000484	CcSEcCtD
Escitalopram—Angiopathy—Doxorubicin—bone cancer	0.000148	0.000482	CcSEcCtD
Escitalopram—Malaise—Methotrexate—bone cancer	0.000148	0.000482	CcSEcCtD
Escitalopram—Muscle spasms—Epirubicin—bone cancer	0.000148	0.000481	CcSEcCtD
Escitalopram—Immune system disorder—Doxorubicin—bone cancer	0.000147	0.00048	CcSEcCtD
Escitalopram—Vertigo—Methotrexate—bone cancer	0.000147	0.00048	CcSEcCtD
Escitalopram—Mediastinal disorder—Doxorubicin—bone cancer	0.000147	0.000479	CcSEcCtD
Escitalopram—Leukopenia—Methotrexate—bone cancer	0.000147	0.000479	CcSEcCtD
Escitalopram—Chills—Doxorubicin—bone cancer	0.000146	0.000477	CcSEcCtD
Escitalopram—Arrhythmia—Doxorubicin—bone cancer	0.000146	0.000475	CcSEcCtD
Escitalopram—Nausea—Cisplatin—bone cancer	0.000145	0.000472	CcSEcCtD
Escitalopram—Vision blurred—Epirubicin—bone cancer	0.000145	0.000472	CcSEcCtD
Escitalopram—Alopecia—Doxorubicin—bone cancer	0.000144	0.00047	CcSEcCtD
Escitalopram—Cough—Methotrexate—bone cancer	0.000143	0.000467	CcSEcCtD
Escitalopram—Mental disorder—Doxorubicin—bone cancer	0.000143	0.000466	CcSEcCtD
Escitalopram—Ill-defined disorder—Epirubicin—bone cancer	0.000142	0.000464	CcSEcCtD
Escitalopram—Convulsion—Methotrexate—bone cancer	0.000142	0.000463	CcSEcCtD
Escitalopram—Erythema—Doxorubicin—bone cancer	0.000142	0.000463	CcSEcCtD
Escitalopram—Malnutrition—Doxorubicin—bone cancer	0.000142	0.000463	CcSEcCtD
Escitalopram—Anaemia—Epirubicin—bone cancer	0.000142	0.000462	CcSEcCtD
Escitalopram—Agitation—Epirubicin—bone cancer	0.000141	0.00046	CcSEcCtD
Escitalopram—Flatulence—Doxorubicin—bone cancer	0.00014	0.000456	CcSEcCtD
Escitalopram—Chest pain—Methotrexate—bone cancer	0.00014	0.000455	CcSEcCtD
Escitalopram—Arthralgia—Methotrexate—bone cancer	0.00014	0.000455	CcSEcCtD
Escitalopram—Myalgia—Methotrexate—bone cancer	0.00014	0.000455	CcSEcCtD
Escitalopram—Tension—Doxorubicin—bone cancer	0.000139	0.000454	CcSEcCtD
Escitalopram—Dysgeusia—Doxorubicin—bone cancer	0.000139	0.000453	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000139	0.000452	CcSEcCtD
Escitalopram—Malaise—Epirubicin—bone cancer	0.000138	0.000451	CcSEcCtD
Escitalopram—Discomfort—Methotrexate—bone cancer	0.000138	0.00045	CcSEcCtD
Escitalopram—Nervousness—Doxorubicin—bone cancer	0.000138	0.00045	CcSEcCtD
Escitalopram—Vertigo—Epirubicin—bone cancer	0.000138	0.000449	CcSEcCtD
Escitalopram—Syncope—Epirubicin—bone cancer	0.000138	0.000449	CcSEcCtD
Escitalopram—Leukopenia—Epirubicin—bone cancer	0.000137	0.000448	CcSEcCtD
Escitalopram—Back pain—Doxorubicin—bone cancer	0.000137	0.000448	CcSEcCtD
Escitalopram—Muscle spasms—Doxorubicin—bone cancer	0.000137	0.000445	CcSEcCtD
Escitalopram—Palpitations—Epirubicin—bone cancer	0.000136	0.000442	CcSEcCtD
Escitalopram—Confusional state—Methotrexate—bone cancer	0.000135	0.00044	CcSEcCtD
Escitalopram—Loss of consciousness—Epirubicin—bone cancer	0.000135	0.00044	CcSEcCtD
Escitalopram—Cough—Epirubicin—bone cancer	0.000134	0.000437	CcSEcCtD
Escitalopram—Anaphylactic shock—Methotrexate—bone cancer	0.000134	0.000436	CcSEcCtD
Escitalopram—Vision blurred—Doxorubicin—bone cancer	0.000134	0.000436	CcSEcCtD
Escitalopram—Convulsion—Epirubicin—bone cancer	0.000133	0.000433	CcSEcCtD
Escitalopram—Infection—Methotrexate—bone cancer	0.000133	0.000433	CcSEcCtD
Escitalopram—Hypertension—Epirubicin—bone cancer	0.000133	0.000432	CcSEcCtD
Escitalopram—Ill-defined disorder—Doxorubicin—bone cancer	0.000132	0.00043	CcSEcCtD
Escitalopram—Nervous system disorder—Methotrexate—bone cancer	0.000131	0.000428	CcSEcCtD
Escitalopram—Anaemia—Doxorubicin—bone cancer	0.000131	0.000428	CcSEcCtD
Escitalopram—Thrombocytopenia—Methotrexate—bone cancer	0.000131	0.000427	CcSEcCtD
Escitalopram—Myalgia—Epirubicin—bone cancer	0.000131	0.000426	CcSEcCtD
Escitalopram—Arthralgia—Epirubicin—bone cancer	0.000131	0.000426	CcSEcCtD
Escitalopram—Chest pain—Epirubicin—bone cancer	0.000131	0.000426	CcSEcCtD
Escitalopram—Agitation—Doxorubicin—bone cancer	0.000131	0.000425	CcSEcCtD
Escitalopram—Anxiety—Epirubicin—bone cancer	0.00013	0.000424	CcSEcCtD
Escitalopram—Skin disorder—Methotrexate—bone cancer	0.00013	0.000424	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.00013	0.000423	CcSEcCtD
Escitalopram—Hyperhidrosis—Methotrexate—bone cancer	0.000129	0.000422	CcSEcCtD
Escitalopram—Discomfort—Epirubicin—bone cancer	0.000129	0.000421	CcSEcCtD
Escitalopram—Malaise—Doxorubicin—bone cancer	0.000128	0.000417	CcSEcCtD
Escitalopram—Dry mouth—Epirubicin—bone cancer	0.000128	0.000417	CcSEcCtD
Escitalopram—Vertigo—Doxorubicin—bone cancer	0.000128	0.000416	CcSEcCtD
Escitalopram—Anorexia—Methotrexate—bone cancer	0.000128	0.000416	CcSEcCtD
Escitalopram—Syncope—Doxorubicin—bone cancer	0.000127	0.000415	CcSEcCtD
Escitalopram—Leukopenia—Doxorubicin—bone cancer	0.000127	0.000414	CcSEcCtD
Escitalopram—Confusional state—Epirubicin—bone cancer	0.000126	0.000412	CcSEcCtD
Escitalopram—Palpitations—Doxorubicin—bone cancer	0.000126	0.000409	CcSEcCtD
Escitalopram—Anaphylactic shock—Epirubicin—bone cancer	0.000125	0.000408	CcSEcCtD
Escitalopram—Oedema—Epirubicin—bone cancer	0.000125	0.000408	CcSEcCtD
Escitalopram—Hypotension—Methotrexate—bone cancer	0.000125	0.000408	CcSEcCtD
Escitalopram—Loss of consciousness—Doxorubicin—bone cancer	0.000125	0.000407	CcSEcCtD
Escitalopram—Infection—Epirubicin—bone cancer	0.000124	0.000406	CcSEcCtD
Escitalopram—Cough—Doxorubicin—bone cancer	0.000124	0.000404	CcSEcCtD
Escitalopram—Shock—Epirubicin—bone cancer	0.000123	0.000402	CcSEcCtD
Escitalopram—Convulsion—Doxorubicin—bone cancer	0.000123	0.000401	CcSEcCtD
Escitalopram—Nervous system disorder—Epirubicin—bone cancer	0.000123	0.0004	CcSEcCtD
Escitalopram—Thrombocytopenia—Epirubicin—bone cancer	0.000123	0.0004	CcSEcCtD
Escitalopram—Hypertension—Doxorubicin—bone cancer	0.000123	0.0004	CcSEcCtD
Escitalopram—Tachycardia—Epirubicin—bone cancer	0.000122	0.000399	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000122	0.000398	CcSEcCtD
Escitalopram—Skin disorder—Epirubicin—bone cancer	0.000122	0.000397	CcSEcCtD
Escitalopram—Hyperhidrosis—Epirubicin—bone cancer	0.000121	0.000395	CcSEcCtD
Escitalopram—Insomnia—Methotrexate—bone cancer	0.000121	0.000395	CcSEcCtD
Escitalopram—Chest pain—Doxorubicin—bone cancer	0.000121	0.000394	CcSEcCtD
Escitalopram—Arthralgia—Doxorubicin—bone cancer	0.000121	0.000394	CcSEcCtD
Escitalopram—Myalgia—Doxorubicin—bone cancer	0.000121	0.000394	CcSEcCtD
Escitalopram—Anxiety—Doxorubicin—bone cancer	0.000121	0.000393	CcSEcCtD
Escitalopram—Paraesthesia—Methotrexate—bone cancer	0.00012	0.000392	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.00012	0.000391	CcSEcCtD
Escitalopram—Discomfort—Doxorubicin—bone cancer	0.000119	0.000389	CcSEcCtD
Escitalopram—Anorexia—Epirubicin—bone cancer	0.000119	0.000389	CcSEcCtD
Escitalopram—Dyspnoea—Methotrexate—bone cancer	0.000119	0.000389	CcSEcCtD
Escitalopram—Somnolence—Methotrexate—bone cancer	0.000119	0.000388	CcSEcCtD
Escitalopram—Dry mouth—Doxorubicin—bone cancer	0.000118	0.000385	CcSEcCtD
Escitalopram—Dyspepsia—Methotrexate—bone cancer	0.000118	0.000384	CcSEcCtD
Escitalopram—Hypotension—Epirubicin—bone cancer	0.000117	0.000382	CcSEcCtD
Escitalopram—Confusional state—Doxorubicin—bone cancer	0.000117	0.000381	CcSEcCtD
Escitalopram—Decreased appetite—Methotrexate—bone cancer	0.000116	0.000379	CcSEcCtD
Escitalopram—Anaphylactic shock—Doxorubicin—bone cancer	0.000116	0.000378	CcSEcCtD
Escitalopram—Oedema—Doxorubicin—bone cancer	0.000116	0.000378	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Methotrexate—bone cancer	0.000116	0.000377	CcSEcCtD
Escitalopram—Fatigue—Methotrexate—bone cancer	0.000115	0.000376	CcSEcCtD
Escitalopram—Infection—Doxorubicin—bone cancer	0.000115	0.000375	CcSEcCtD
Escitalopram—Pain—Methotrexate—bone cancer	0.000114	0.000373	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000114	0.000372	CcSEcCtD
Escitalopram—Shock—Doxorubicin—bone cancer	0.000114	0.000372	CcSEcCtD
Escitalopram—Nervous system disorder—Doxorubicin—bone cancer	0.000114	0.000371	CcSEcCtD
Escitalopram—Thrombocytopenia—Doxorubicin—bone cancer	0.000114	0.00037	CcSEcCtD
Escitalopram—Insomnia—Epirubicin—bone cancer	0.000113	0.000369	CcSEcCtD
Escitalopram—Tachycardia—Doxorubicin—bone cancer	0.000113	0.000369	CcSEcCtD
Escitalopram—Skin disorder—Doxorubicin—bone cancer	0.000113	0.000367	CcSEcCtD
Escitalopram—Paraesthesia—Epirubicin—bone cancer	0.000113	0.000367	CcSEcCtD
Escitalopram—Hyperhidrosis—Doxorubicin—bone cancer	0.000112	0.000365	CcSEcCtD
Escitalopram—Dyspnoea—Epirubicin—bone cancer	0.000112	0.000364	CcSEcCtD
Escitalopram—Somnolence—Epirubicin—bone cancer	0.000111	0.000363	CcSEcCtD
Escitalopram—Anorexia—Doxorubicin—bone cancer	0.000111	0.00036	CcSEcCtD
Escitalopram—Feeling abnormal—Methotrexate—bone cancer	0.00011	0.00036	CcSEcCtD
Escitalopram—Dyspepsia—Epirubicin—bone cancer	0.00011	0.000359	CcSEcCtD
Escitalopram—Gastrointestinal pain—Methotrexate—bone cancer	0.000109	0.000357	CcSEcCtD
Escitalopram—Decreased appetite—Epirubicin—bone cancer	0.000109	0.000355	CcSEcCtD
Escitalopram—Hypotension—Doxorubicin—bone cancer	0.000108	0.000353	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Epirubicin—bone cancer	0.000108	0.000353	CcSEcCtD
Escitalopram—Fatigue—Epirubicin—bone cancer	0.000108	0.000352	CcSEcCtD
Escitalopram—Pain—Epirubicin—bone cancer	0.000107	0.000349	CcSEcCtD
Escitalopram—Constipation—Epirubicin—bone cancer	0.000107	0.000349	CcSEcCtD
Escitalopram—Urticaria—Methotrexate—bone cancer	0.000106	0.000347	CcSEcCtD
Escitalopram—Abdominal pain—Methotrexate—bone cancer	0.000106	0.000345	CcSEcCtD
Escitalopram—Body temperature increased—Methotrexate—bone cancer	0.000106	0.000345	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000106	0.000344	CcSEcCtD
Escitalopram—Insomnia—Doxorubicin—bone cancer	0.000105	0.000342	CcSEcCtD
Escitalopram—Paraesthesia—Doxorubicin—bone cancer	0.000104	0.000339	CcSEcCtD
Escitalopram—Dyspnoea—Doxorubicin—bone cancer	0.000103	0.000337	CcSEcCtD
Escitalopram—Feeling abnormal—Epirubicin—bone cancer	0.000103	0.000336	CcSEcCtD
Escitalopram—Somnolence—Doxorubicin—bone cancer	0.000103	0.000336	CcSEcCtD
Escitalopram—Gastrointestinal pain—Epirubicin—bone cancer	0.000102	0.000334	CcSEcCtD
Escitalopram—Dyspepsia—Doxorubicin—bone cancer	0.000102	0.000333	CcSEcCtD
Escitalopram—Decreased appetite—Doxorubicin—bone cancer	0.000101	0.000328	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Doxorubicin—bone cancer	0.0001	0.000326	CcSEcCtD
Escitalopram—Fatigue—Doxorubicin—bone cancer	0.0001	0.000326	CcSEcCtD
Escitalopram—Urticaria—Epirubicin—bone cancer	9.95e-05	0.000324	CcSEcCtD
Escitalopram—Pain—Doxorubicin—bone cancer	9.91e-05	0.000323	CcSEcCtD
Escitalopram—Constipation—Doxorubicin—bone cancer	9.91e-05	0.000323	CcSEcCtD
Escitalopram—Abdominal pain—Epirubicin—bone cancer	9.9e-05	0.000323	CcSEcCtD
Escitalopram—Body temperature increased—Epirubicin—bone cancer	9.9e-05	0.000323	CcSEcCtD
Escitalopram—Hypersensitivity—Methotrexate—bone cancer	9.86e-05	0.000321	CcSEcCtD
Escitalopram—Asthenia—Methotrexate—bone cancer	9.61e-05	0.000313	CcSEcCtD
Escitalopram—Feeling abnormal—Doxorubicin—bone cancer	9.55e-05	0.000311	CcSEcCtD
Escitalopram—Gastrointestinal pain—Doxorubicin—bone cancer	9.48e-05	0.000309	CcSEcCtD
Escitalopram—Pruritus—Methotrexate—bone cancer	9.47e-05	0.000309	CcSEcCtD
Escitalopram—Hypersensitivity—Epirubicin—bone cancer	9.23e-05	0.000301	CcSEcCtD
Escitalopram—Urticaria—Doxorubicin—bone cancer	9.21e-05	0.0003	CcSEcCtD
Escitalopram—Body temperature increased—Doxorubicin—bone cancer	9.16e-05	0.000299	CcSEcCtD
Escitalopram—Abdominal pain—Doxorubicin—bone cancer	9.16e-05	0.000299	CcSEcCtD
Escitalopram—Diarrhoea—Methotrexate—bone cancer	9.16e-05	0.000299	CcSEcCtD
Escitalopram—Asthenia—Epirubicin—bone cancer	8.99e-05	0.000293	CcSEcCtD
Escitalopram—Pruritus—Epirubicin—bone cancer	8.86e-05	0.000289	CcSEcCtD
Escitalopram—Dizziness—Methotrexate—bone cancer	8.85e-05	0.000289	CcSEcCtD
Escitalopram—Diarrhoea—Epirubicin—bone cancer	8.57e-05	0.000279	CcSEcCtD
Escitalopram—Hypersensitivity—Doxorubicin—bone cancer	8.54e-05	0.000278	CcSEcCtD
Escitalopram—Vomiting—Methotrexate—bone cancer	8.51e-05	0.000277	CcSEcCtD
Escitalopram—Rash—Methotrexate—bone cancer	8.44e-05	0.000275	CcSEcCtD
Escitalopram—Dermatitis—Methotrexate—bone cancer	8.43e-05	0.000275	CcSEcCtD
Escitalopram—Headache—Methotrexate—bone cancer	8.39e-05	0.000273	CcSEcCtD
Escitalopram—Asthenia—Doxorubicin—bone cancer	8.32e-05	0.000271	CcSEcCtD
Escitalopram—Dizziness—Epirubicin—bone cancer	8.29e-05	0.00027	CcSEcCtD
Escitalopram—Pruritus—Doxorubicin—bone cancer	8.2e-05	0.000267	CcSEcCtD
Escitalopram—Vomiting—Epirubicin—bone cancer	7.97e-05	0.00026	CcSEcCtD
Escitalopram—Nausea—Methotrexate—bone cancer	7.95e-05	0.000259	CcSEcCtD
Escitalopram—Diarrhoea—Doxorubicin—bone cancer	7.93e-05	0.000258	CcSEcCtD
Escitalopram—Rash—Epirubicin—bone cancer	7.9e-05	0.000257	CcSEcCtD
Escitalopram—Dermatitis—Epirubicin—bone cancer	7.89e-05	0.000257	CcSEcCtD
Escitalopram—Headache—Epirubicin—bone cancer	7.85e-05	0.000256	CcSEcCtD
Escitalopram—Dizziness—Doxorubicin—bone cancer	7.67e-05	0.00025	CcSEcCtD
Escitalopram—Nausea—Epirubicin—bone cancer	7.44e-05	0.000243	CcSEcCtD
Escitalopram—Vomiting—Doxorubicin—bone cancer	7.37e-05	0.00024	CcSEcCtD
Escitalopram—Rash—Doxorubicin—bone cancer	7.31e-05	0.000238	CcSEcCtD
Escitalopram—Dermatitis—Doxorubicin—bone cancer	7.3e-05	0.000238	CcSEcCtD
Escitalopram—Headache—Doxorubicin—bone cancer	7.26e-05	0.000237	CcSEcCtD
Escitalopram—Nausea—Doxorubicin—bone cancer	6.89e-05	0.000224	CcSEcCtD
